In Brief - Asia

* US-based private equity group Shah Capital Management has gradually been increasing its holding in Bio-Treat Technology, and currently owns 9.62% of the company.

Shah clearly saw the recent market downturn as a ‘buy’ opportunity, and has been gradually incrementing its stake ever since. It clearly believes in Bio- Treat’s business model, though it may have to give up some of its profits to sort out the mess left by the company’s convertible bond issue. Bio-Treat announced on 14 October that it ...

Subscription required

To read this full article you must be subscribed to Global Water Intelligence.
Subscribe Now, Sign up for a Free Trial or Log In